文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

家族性渗出性玻璃体视网膜病变相关孔源性视网膜脱离中的二代测序研究

Next-Generation Sequencing in the Familial Exudative Vitreoretinopathy-Associated Rhegmatogenous Retinal Detachment.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究为连续横断面研究,纳入54例中国家族性渗出性玻璃体视网膜病变相关孔源性视网膜脱离(FEVR-RRD)患者,行全面眼科检查与靶向二代测序。38.9%(21/54)检出致病突变,以LRP5为主(14/54)。LRP5突变患者的视网膜血管渗漏或新生血管少于TSPAN12/FZD4突变患者。

要点

  • 54例FEVR-RRD患者中38.9%(21/54)检出致病突变,LRP5占14/54。
  • FZD4突变者LAPPEL 100%(4/4),TSPAN12突变者100%(3/3),LRP5突变者42.9%(6/14)。
  • FZD4突变者ERNV 100%(4/4),TSPAN12突变者66.7%(2/3),LRP5突变者21.4%(3/14)。

核心结论

  • 已知FEVR相关基因的致病突变阳性率为38.9%(21/54),LRP5突变占遗传阳性患者的66.7%(14/21),为主要突变基因。
  • LRP5突变所致FEVR-RRD患者的视网膜血管渗漏或新生血管少于TSPAN12/FZD4突变所致者。
  • 研究共发现14个新变异,增进了对该疾病的认识。

研究设计与样本

  • 连续、横断面研究,纳入54例FEVR-RRD患者。
  • 所有患者接受全面眼科检查和靶向二代测序,并分析基因型-表型关联。

主要发现

  • 致病突变检出38.9%(21/54),其中LRP5 14/54、FDZ4 4/54、TSPAN12 3/54。
  • 在21例无亲缘关系的FEVR先证者中鉴定出22个潜在致病突变,14个为新变异(LRP5 10/15、FZD4 1/4、TSPAN12 3/3)。
  • LAPPEL见于FZD4突变者100%(4/4)、TSPAN12突变者100%(3/3),LRP5突变者仅42.9%(6/14)。
  • ERNV见于FZD4突变者100%(4/4)、TSPAN12突变者66.7%(2/3),LRP5突变者仅21.4%(3/14)。

关键数值与推荐

  • 致病突变阳性率38.9%(21/54)。
  • LRP5突变占遗传阳性患者的66.7%(14/21)。
  • LAPPEL在FZD4突变者4/4、TSPAN12突变者3/3、LRP5突变者6/14中检出。
  • ERNV在FZD4突变者4/4、TSPAN12突变者2/3、LRP5突变者3/14中检出。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to investigate the genetic mutation spectrum in Chinese patients with familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment (FEVR-RRD) and to analyze the preliminary genotype-phenotype association. METHODS: In this consecutive, cross-sectional study, 54 patients with FEVR-RRD were studied. Comprehensive ophthalmic examinations and targeted next-generation sequencing were performed in all patients. The genotype-phenotype association was also analyzed. RESULTS: Causative mutations were identified in 38.9% (21/54) of patients (14/54 in LRP5, 4/54 in FDZ4, and 3/54 in TSPAN12). The study identified 22 potentially pathogenic mutations in 21 unrelated FEVR probands, and 14 were novel (10/15 in LRP5, 1/4 in FZD4, and 3/3 in TSPAN12). Furthermore, to explore the genotype-phenotype association, late-phase angiographic posterior and peripheral leakage (LAPPEL) was identified in 100% (4/4) of patients with FZD4 mutations and 100% (3/3) of patients with TSPAN12 mutations but only in 42.9% (6/14) of patients with LRP5 mutations. Extraretinal neovascularization (ERNV) was found in 100% (4/4) of patients with FZD4 mutations and in 66.7% (2/3) of patients with TSPAN12 mutations, but only in 21.4% (3/14) of patients with LRP5 mutations. CONCLUSIONS: The positive rate for pathogenic mutations in the known FEVR-associated genes was 38.9% (21/54). Among the mutations, LRP5 mutation was the predominant, accounting for 66.7% (14/21) of genetic positive patients. Patients with FEVR-RRD due to LRP5 mutations have less retinal vascular leakage or neovasculization than do patients with FEVR-RRD due to TSPAN12/FZD4 mutations. Moreover, 14 novel variants were found, which provided a deeper understanding of this disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chen C, Wang Z, Sun L, et al. Next-Generation Sequencing in the Familial Exudative Vitreoretinopathy-Associated Rhegmatogenous Retinal Detachment. Invest Ophthalmol Vis Sci. 2019. PMID: 31237656. doi:10.1167/iovs.19-26619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。